Attenuation by phosphodiesterase inhibitors of lipopolysaccharide- induced thromboxane release and bronchoconstriction in rat lungs

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1453-1459

  Uhlig, Stefan ^a   Featherstone, Roland Lewis ^a   Held, Heinz Dieter ^a   Nüsing, Rolf ^c   Schudt, Christian ^b   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYCLIC AMP; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; MOTAPIZONE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; THROMBOXANE; ZARDAVERINE;

ANIMAL TISSUE; ARTICLE; BRONCHIOLE; BRONCHODILATATION; BRONCHOSPASM; FEMALE; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE;

ANIMALS; BRONCHOCONSTRICTION; CYCLIC AMP; FEMALE; LIPOPOLYSACCHARIDES; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; THROMBOXANES;

EID: 0031473317     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. APPLEBY, S. B., RISTIMAKI, A., NEILSON, K., NARKO, K. AND HLA, T.: Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 302: 723-727, 1994.
2. 2 synthesis: An in vitro study. Thromb. Res. 71: 227-236, 1993.
3. BAUER, A. C., SCHWABE, U.: An improved assay of cyclic 3′,5′-nucleotide phosphodiesterase with QAE Sephadex A25. Naunyn-Schmiedeberg's Arch. Pharmacol. 311: 193-198, 1980.
4. BEAVO, J. A. AND REIFSNYDER, D. H.: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11: 150-155, 1990
5. BERGER, J. I., GIBSON, R. L., CLARKE, W. R., STANDAERT, T. A., REDDING, G. J., HENDERSON, W. R. AND TRUOG, W. E.: Effect of amrinone during group B Streptococcus-induced pulmonary hypertension in piglets. Pediatr. Pulmonol. 16: 303-310, 1993.
6. DE BOER, J., PHILPOTT, A. J., VAN AMSTERDAM, R. G. M., SHAHID, M., ZAAGSMA, J. AND NICHOLSON, C. D.: Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: Biochemical and pharmacological analysis using selective inhibitors. Br. J. Pharmacol. 106: 1028-1034, 1992.
7. FISCHER, W., SCHUDT, C. AND WENDEL, A.: Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45: 2399-2404, 1993.
8. GANTNER, F., KUPFERSCHMIDT, R., SCHUDT, C., WENDEL, A. AND HATZELMANN, A.: In vitro differentiation of human monocytes to macrophages: Change of PDE profile and its relationship to suppression of tumour necrosis factor-α release by PDE inhibitors. Br. J. Pharmacol. 121: 221-231, 1997.
9. GIROIR, B. P. AND BEUTLER, B.: Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ. Shock 36: 200-207, 1992.
10. HELD, H-D., WENDEL, A. AND UHLIG, S.: Phosphodiesterase inhibitors prevent endothelin-1-induced vasoconstriction, bronchoconstriction and thromboxane release in perfused rat lung. Biochem. Biophys. Res. Commun. 231: 22-25, 1997.
11. HICHAMI, A., BIOCHOT, E., GERMAIN, N., LEGRAND, A., MOODLEY, I. AND LAGENTE, V.: Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells. Eur. J. Pharmacol. 291: 91-97, 1995.
12. 2+ uptake by human platelets. Eur. J. Pharmacol. 245: 67-73, 1993.
13. KIPS, J. C., JOOS, G. F., PELEMAN, R. A. AND PAUWELS, R. A.: The effect of zardaverine, an inhibitor of phosphodiesterase isoenzymes III and IV, on endotoxin-induced airway changes in rats. Clin. Exp. Allergy 23: 518-523, 1993.
14. KOBAYASHI, H., KOBAYASHI, T. AND FUKUSHIMA, M.: Effects of dibutyryl cAMP on pulmonary air embolism-induced lung injury in awake sheep. J. Appl. Physiol. 63: 2201-2207, 1987.
15. KOYAMA, S., TOYOFUKU, T., HIRAI, K., YOSHIMURA, K., SAKAI, A. AND KOBAYASHI, T.: Dibutyryl cyclic AMP attenuates lung responses induced by endotoxin in conscious sheep. Am. Rev. Respir. Dis. 146: 32-38, 1992.
16. LEIST, M., AUER-BARTH, S. AND WENDEL, A.: Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines. J. Pharmacol. Exp. Ther. 276: 968-976, 1996.
17. LI, J. X., OLIVER, J. R., LU, C. Y. AND PHILIPS, J. B.: Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. Am. J. Med. Sci. 310: 103-110, 1995.
18. 2alpha synthesis in mouse hepatocytes. Prostaglandins 36: 761-772, 1988.
19. MASOUYE, P., GUNING, K., PITTET, J. F., SUTER, P. M. AND MOREL, D. R.: Xanthine derivative HWA138 attenuates hemodynamic and oxygen uptake dysfunction secondary to severe endotoxin shock in sheep. Circ. Shock 36: 113-119, 1992.
20. MARTIN, C., BRASCH, F., MÜLLER K.-M., ULLRICH V. AND UHLIG, S.: Thromboxane preferentially contracts smaller airways in rat lung. Am. J. Respir. Crit. Care Med. 153: A687, 1996.
21. 2 enzymes: Regulation and physiological role. Biochem. Pharmacol. 48: 1-10, 1994
22. 2, D but not C. Comp. Biochem. Physiol. 112C: 137-143, 1995.
23. 2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesanglial cells. Biochem. J. 313: 617-623, 1996.
24. 2+ influx in vascular smooth muscle cells. Hypertension 27: 774-780, 1996.
25. PELOSI, P., CEREDA, M., FOTI, G., GIACOMINI, M. AND PESENTI, A.: Alterations of lung and chest wall mechanics in patients with acute lung injury: effect of positive end-expiratory pressure. Am. J. Respir. Crit. Care Med. 152: 531-537, 1995.
26. POST, M. J., BIESEBEEK, J. D. T., WEMER, J., VANROOIJ, H. H., ZIJLSTRA, F. J., VERMEER, M. A. AND PORSIUS, A. J.: Effects of milrinone and salbutamol on antigen induced arachidonic acid metabolism in the isolated rat lung. Biochem. Pharmacol. 38: 2573-2574, 1989.
27. RABE, K. F., TENOR, H., DENT, G., SCHUDT, C., LIEBIG, S. AND MAGNUSSEN, H.: Phosphodiesterase isozymes modulating inherent tone in human airways: Identification and characterization. Am. J. Physiol. 264: L458-L464, 1993.
28. RABE, K. F., MAGNUSSEN, H. AND DENT, G.: Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur. Respir. J. 8: 637-642, 1995.
29. 4 and PAF. Mediators Inflamm. 1: 5-8, 1992.
30. 2 suppresses tumor necrosis factor but not interleukin-1α or β-mRNA and cell-associated bioactivity. J. Leukocyte Biol. 45: 416-421, 1989.
31. i. Naunyn-Schmiedeberg's Arch. Pharmacol. 344: 682-690, 1991a.
32. SCHUDT, C., WINDER, S., MÜLLER, B. AND UKENA, D.: Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem. Pharmacol. 42: 153-162, 1991b.
33. SCHUDT, C., TENOR, H. AND HATZELMANN, A.: PDE isoenzymes as targets for anti-asthma drugs. Eur. Respir. J. 8: 1179-1183, 1995.
34. SELDON, P. M., BARNES, P. J., MEJA, K. AND GIEMBYCZ, M. A.: Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from peripheral blood monocytes by inhibitors of phosphodiesterase 4: Interaction with stimulants of adenylyl cyclase. J. Pharmacol. Exp. Ther. 48: 747-757, 1995.
35. SOUNESS, J. E. AND GIEMBYCZ, M. A.: (1994) Cyclic nucleotide phosphodiesterases in airway smooth muscle. In Airway Smooth Muscle: Biochemical Control of Contraction and Relaxation, ed. by D. Raeburn and M. A. Giembycz, chap. 13, pp. 271-308, Birkhäuser, Basel.
36. SOUNESS, J. E., VILLAMIL, M. E., SCOTT, L. C., TOMKINSON, A., GIEMBYCZ, M. A. AND RAEBURN, D.: Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Br. J. Pharmacol. 111: 1091-1088, 1994.
37. SPRIGGS, D. R., DEUTSCH, S. AND KUFE, D. W.: Genomic structure, induction, and production of TNF-alpha. Immunol. Ser. 56: 3-34, 1992.
38. THOMPSON, W. J. AND APPLEMAN, M. M.: Assay of cyclic nucleotide phosphodiesterase and resolution of multiple forms of the enzyme. Adv. Cyclic Nucl. Res. 10: 69-92, 1979.
39. TURNER, C. R., ESSER, K. M. AND WHEELDON, E. B.: Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition. Circ. Shock 39: 237-245, 1993.
40. UHLIG, S. AND WENDEL, A.: Lipid mediators in perfused lung. In Interdisziplinäre Aspekte der Pneumologie, ed. by P. von Wichert and W. Siegenthaler, pp 66-74, Georg Thieme Verlag, Stuttgart, Germany, 1995.
41. UHLIG, S. AND WOLLIN, L.: An improved setup for the isolated perfused rat lung. J. Pharm. Tox. Methods 31: 85-94, 1994.
42. UHLIG, S., BRASCH, F., WOLLIN, L., FEHRENBACH, H., RICHTER, J. AND WENDEL, A.: Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am. J. Pathol. 146: 1235-1247, 1995.
43. UHLIG, S., NÜSING, R., VON BETHMANN, A., FEATHERSTONE, R. L., KLEIN, T., BRASCH, F., MÜLLER, K.-M., ULLRICH, V. AND WENDEL, A.: Cyclooxygenase-2 dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol. Med. 2: 373-383, 1996.
44. UNDERWOOD, D. C., KOTZER, C. J., BOCHNOWICZ, S., OSBORN, R. R., LUTTMANN, M. A., HAY, D. W. AND TORPHY, T. J.: Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmacol. Exp. Ther. 270: 250-259, 1994.
45. WRIGHT, P. E., CARMICHAEL, L. C. AND BERNARD, G. R.: Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome. Chest 106: 1517-1523, 1994.
46. ZAR, J. H.: Biostatistical Analysis, Prentice-Hall, Englewood-Cliffs, NJ, p. 239, 1984.